PEC vs Taiwan Biomaterial: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Taiwan Biomaterial (6649) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Taiwan Biomaterial

0%+108%-78%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYTaiwan BiomaterialYoY
Oct 2026NT$2.84 billion+102.0%NT$12.4 million-34.1%
Sep 2026NT$2.64 billion+100.0%NT$17 million-49.3%
Aug 2026NT$2.62 billion+105.4%NT$14.4 million-32.8%
Jul 2026NT$2.51 billion+92.6%NT$12.4 million-30.3%
Jun 2026NT$2.33 billion+94.9%NT$13.1 million+16.5%
May 2026NT$2.46 billion+108.5%NT$12.3 million-9.9%
Apr 2026NT$2.06 billion+68.3%NT$11.5 million+29.9%
Mar 2026NT$1.94 billion+64.4%NT$11.5 million-38.2%
Feb 2026NT$1.6 billion+56.7%NT$7.2 million-78.3%
Jan 2026NT$1.58 billion+49.8%NT$7.7 million-51.5%
Dec 2025NT$1.92 billion+69.9%NT$16.9 million+61.5%
Nov 2025NT$1.55 billion+53.0%NT$10.6 million+18.8%
Oct 2025NT$1.4 billion+53.6%NT$18.8 million+93.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16